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abstract: This article narrates a multifaceted educational journey undertaken by a medical student through 
a weekly SCRAPS (surgery, clinical disciplines, radiology, anatomy, psychiatry and laboratory sciences) clinico-
pathological meeting held in the College of Medicine & Health Sciences at Sultan Qaboos University in Muscat, 
Oman. Through a presentation titled ‘Unveiling Cancer’, the multidisciplinary and interprofessional audience 
witnessed a simulated interaction between a medical student, a technologist peer and tutors in medicine, pathology 
and radiology. The presentation was based on the complexities of presentation, diagnosis and management of a 
patient with anaplastic large cell lymphoma, a rare type of non-Hodgkin lymphoma, in the aftermath of a bone 
marrow transplantation. After describing the case, the student shared with the audience a spectrum of learning 
objectives, which included integration in the complex world of contemporary medicine, insight into the triumphs 
and travails of technology (immunohistochemistry) and peer collaboration, communication and mentorship.
Keywords: Clinico-Pathological Conference; Anaplastic Large-Cell Lymphoma; Immunohistochemistry; Medical 
Education; Oman.
امللخ�ص: ي�سف هذا املقال رحلة علمية متعددة اجلوانب قام بها طالب طب يف ملتقى عيادي-باثولوجي يعقد اأ�سبوعيا يف كلية الطب 
العيادية  لتقدمي حما�رسات وحالت مر�سية يف علوم اجلراحة واملواد  ال�سلطان قابو�س يف م�سقط بعمان  ال�سحية يف جامعة  والعلوم 
والأ�سعة والت�رسيح والأمرا�س الع�سبية والنف�سية وعلوم املختربات )يعرف اخت�سارا بـ SCRAPS(. ويف ذلك امللتقى قدم الطالب للح�سور 
)وهم من تخ�س�سات علمية ومهنية خمتلفة( حما�رسة بعنوان "اإزاحة ال�ستار عن ال�رسطان" اأتاحت فر�سة طيبة لإثارة تفاعل بني طالب 
طب واأحد الأقران من الفنيني واأ�ساتذة يف الطب والأ�سعة وعلم الأمرا�س. وكان اأ�سا�س املحا�رسة املقدمة يعتمد على التعقيدات يف عر�س 
احلالة وت�سخي�سها واأ�سلوب معاجلتها يف مري�س كان م�سابا برسطان الغدد اللمفاوية الكشمي الالهودجكيني كبرية اخللية )وهي نوع نادر 
احلدوث من اللمفوما الالهودجكينة( حدثت نتيجة لنقل نقي العظام. وبعد اأن قدم الطالب احلالة اأ�رسك الطالب احلا�رسين يف طيف من 
اأهداف التعلم والتي �سملت التكامل يف عامل معقد من الطب الع�رسي، وتب�رس نافذ يف انت�سارات وإخفاقات التقنية )الكيمياء الهي�ستولوجية 
املناعية(، والتعاون بني الزمالء والأقران والتوا�سل والإر�ساد.
مفتاح الكلمات: ملتقى عيادي-باثولوجي؛ ملفومة ك�سمية لهودجكينة كبرية اخللية؛ الكيمياء الهي�ستولوجية املناعية؛ التعليم الطبي؛ عمان.
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continuing medical education
The acronym ‘scraps’ stands for surgery, clinical disciplines, radiology, anatomy, psychiatry and laboratory sciences and it is the 
name of a weekly clinico-pathological forum held at 
the College of Medicine & Health Sciences (COMHS) 
at Sultan Qaboos University (SQU) in Muscat, Oman. 
The forum is a one-hour interdisciplinary presentation 
of clinical cases with educational value for faculty 
and clerkship students, usually steered by divisions 
of medicine and surgery with diagnostic input. In a 
significant diversion from this practice, a pathology-
led SCRAPS session was used to focus on a triumvirate 
that is the foundation of 21st century academic clinical 
practice, in a presentation called ‘Unveiling Cancer’. 
Firstly, its educational objective aimed at unifying 
and dissecting the complexities and challenges 
of disease arising from advances in therapy and 
technology.1 Secondly, it offered an insightful analysis 
of the triumphs and travails of technology, using 
immunohistochemistry (IHC) as an example. Thirdly, 
it highlighted the interdependency and need for 
dialogue among interdisciplinary and interprofessional 
health providers. The whole exercise was designed to 
simulate the learning journey undertaken by a medical 
graduate in a clinical scenario, mentored by a team 
of educators, which unfolded in a staged format to 
engage the audience.2
At the Bedside
A junior clerkship student presented a patient’s clinical 
profile to his physician-educator.
A 24-year-old male patient presented with a 
two-week history of shortness of breath on mild 
exertion. There was no history of cough, chest pain 
or palpitations, nor was there any recent history of 
fever or weight loss. However, he had noticed a mass in 
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the left thigh over the past one month. The patient had 
undergone an allogeneic bone marrow transplant (BMT) 
for thalassaemia major 12 years previously, using high 
doses of alkylating agents as conditioning chemotherapy. 
On examination, he was a fit young man, not pale or 
icteric and with no peripheral lymphadenopathy. A 
respiratory system examination revealed he had reduced 
chest movement, a dull percussion note, reduced breath 
sounds and an increased vocal fremitus on the right side in 
the lower third of the chest. He was not anaemic but had 
polymorphonuclear leucocytosis and thrombocytosis. 
The prothrombin time showed a mild increase in the 
international normalised ratio.
Shadows of Disease
The radiologist recounted the salient imaging findings 
for the audience. 
An X-ray of the chest revealed a right lower lobe 
collapse, confirmed via computerised tomography of 
the chest, abdomen and pelvis [Figure 1]. A small soft 
tissue mass was seen projecting within the lumen of 
the right bronchus intermedius with no significant 
focal enhancement. There was no significant thoracic 
or abdominal lymphadenopathy. The right adrenal 
gland showed an irregular 2 x 3.4 cm well-defined 
internally degenerated mass with mural enhancement. 
A bronschoscopy revealed an endobronchial mass. 
Magnetic resonance imaging of the left thigh 
revealed an oval solid mass (15.7 x 6.3 cm) in the 
medial aspect of the lower half of the thigh, engulfing 
the belly of the gracilis muscle, extending and splaying 
the adductor magnus and sartorius muscles; it 
showed heterogenous enhancement. The neuro-
vascular bundle and bones were free. Overlying skin 
and subcutaneous tissue were thickened. A diagnosis 
of sarcoma was suggested, requiring confirmation by 
biopsy [Figure 2].
The student analysed the case and suggested 
to the tutor that the two masses probably had the 
same aetiology. The physician and student debated 
the biopsy diagnosis of the endobronchial mass 
and the thigh mass, which had been categorised as 
small round blue cell tumours (SRCT). Following 
immunophenotyping, the former was diagnosed as a 
primitive neuroectodermal tumour (PNET) and the 
latter as an anaplastic large cell lymphoma (ALCL). 
The student expressed uncertainty in comprehending 
the application of IHC that led to these divergent 
diagnoses. The physician suggested that the student 
solve this dilemma by going to the laboratory to acquire 
clarity on the concepts of usage and interpretation 
of IHC.
A Quest for Knowledge
The student approached his former pathology teachers 
to fill the gaps in his knowledge.
The pathologist-educator was surprised and 
delighted with the young student’s sense of purpose 
in resolving clinical applications of laboratory 
techniques. She recommended a short ‘back to basics’ 
tutorial on the principles of IHC to the medical clerk, 
provided by the student’s biomedical sciences peer, 
in order to initiate his understanding of IHC. The 
technologist-student succinctly explained it as an 
application of the immunologic principle of antigen-
antibody reaction on tumour tissues. In tumours which 
are poorly differentiated on morphology, the antigenic 
 
Figure 1A & B: Chest imaging (A) X-ray and (B) computed tomography scan showing a right lower lobe collapse and 
endobronchial mass.
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Ewing’s sarcoma/PNET and small cell (neuroendo-
crine) carcinoma. He illustrated a ‘shopping cart’ 
of antibodies, from which a panel was selected to 
‘unveil’ the poorly differentiated tumour in the patient 
[Figure 3]. The first biopsy, in a small and crushed 
sample (bronchial mass), showed immunoreactivity 
to cluster of differentiation (CD) 99 and CD30 and 
was negative for leukocyte common antigen (LCA; a 
commonly employed lymphoma marker); hence the 
PNET interpretation. The second larger and better 
preserved biopsy (the thigh mass) showed positivity 
for the previous two antigens as well as additional 
markers: anaplastic lymphoma kinase (ALK)-1 and 
CD43 [Figure 4]. This led to a final diagnosis of ALCL. 
Both masses represented ALCL on final review.
With this patient as an example, the pathologist 
listed several pitfalls in the contextual interpretation 
of IHC: small and poorly preserved tissue resulted in 
a challenge for interpretation; the primary site would 
have been the better and more reliable biopsy source 
for antigenic expression; antibodies like CD99 are 
cross-reactive with other tumours; and LCA, which 
is usually expressed in lymphoid cells, is negative 
in ALCL (a rare type of lymphoma).3–5 He also 
explained that ALK immunohistochemical positivity 
in ALCL was due to the abnormal accumulation of 
a chimeric protein due to a nucleophosmin (NPM)1-
ALK translocation t(2;5)(p23;35), which can be further 
confirmed by fluorescence in situ hybridisation.
The student completed his laboratory search for 
the final diagnosis and returned to the physician-
tutor to discuss this unusual and educative case and 
its management.
fidelity in specific tumours could be identified in vitro 
by the application of the corresponding antibody 
on sections of the tumour tissue, thus ‘unveiling’ its 
histogenetic differentiation. This, in turn, would direct 
the choice of therapy or provide an insight into the 
tumour’s biological behaviour. 
Armed with this knowledge the medical student 
proceeded to meet the reporting pathologist to demystify 
the two divergent diagnoses rendered in the patient.
The ‘Final’ Diagnosis
The reporting pathologist listed a short differential 
diagnosis for SRCT in this young adult including 
rhabdomyosarcoma, non-Hodgkin lymphoma (NHL), 
 
Figure 2A & B: A: Computed tomography scan of the abdomen, showing an irregular mass in the right adrenal gland. B: 
Magnetic resonance imaging of the thigh, showing a large oval solid soft tissue mass in the medial aspect of the lower thigh.
 
Figure 3: Shopping cart illustrating the panel of 
antibodies used for immunophenotypic characterisation 
of the biopsies from the bronchial and thigh masses.
LCA = leukocyte common antigen; MYOD1 = myoblast 
determination protein 1; CD = cluster of differentiation. 
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Figure 4A & B: Haematoxylin and eosin stains of biopsies from the (A) bronchial mass and (B) thigh mass showing a 
malignant round blue cell tumour at x100 magnification. Boxes display immunohistochemistry patterns in both biopsies: 
CD99, CD30 positive/LCA negative. Additional markers on the thigh biopsy clinched the diagnosis of anaplastic large 
cell lymphoma by immunoreactivity for ALK and CD43.
CD = cluster of differentiation; LCA = leukocyte common antigen; ALK = anaplastic lymphoma kinase.
Complexities of 21st Century 
Cancer Management
After the student had recounted his learning 
experience, the physician outlined the two questions 
he should now consider as a medical student. First, in 
view of the past treatment for thalassaemia major with 
allogeneic bone marrow transplantation, could the 
ALCL be regarded as a ‘secondary’ cancer? Second, 
what was unique about ALCL which justified the 
elaborate attempts made to accurately characterise 
this type of NHL?
Firstly, in 21st century practice of medicine, the 
success of a cancer cure comes with the downside of 
diagnosis and the treatment of ‘secondary’ cancers 
that arise on a background of immunosuppression. 
Immunosuppression may be secondary to therapy 
(chemoradiotherapy or conditioning for BMT) or due 
to the first malignancy itself, such as haematolymphoid 
malignancies.6 The incidence increases with time and 
is approximately 15% at 15–20 years from the time 
of the first treatment.6 Secondary cancers are usually 
acute non-lymphocytic leukaemia, NHL or solid 
tumours (especially in the field of radiation). Amongst 
NHL, the most common sub-type is B-cell lymphoma; 
if immunosuppression-driven, it is associated with the 
Epstein-Barr virus. This patient received high doses of 
alkylating agents as part of the conditioning regimen 
for BMT and this may well have caused the ALCL. 
The second question relates to understanding 
ALCL; this is one of the several types of mature T/
natural killer (NK)-cell lymphomas, accounting for 
almost a quarter of all the T/NK-cell lymphomas in 
North America, around 6% of the T cell lymphomas in 
Asia and 10% of all NHLs in Oman.7–9 ALCL presents 
either with cutaneous involvement only (cALCL) or 
with systemic involvement (sALCL).10 The significant 
majority of patients with sALCL have a translocation 
t(2;5) causing a NPM-ALK fusion gene, resulting in 
an 80 kilodalton protein. An IHC demonstration of 
this protein is helpful in several ways: in diagnosing 
difficult cases (as in this patient), defining the 
prognosis and as a predictive marker for treatment 
with a specific tyrosine kinase inhibitor (crizotinib).11 
The presence of ALK translocation is an independent 
favourable prognostic factor. ALK-positive cALCL 
usually presents in the first three decades of life and, 
despite the advanced stage at presentation, has a better 
prognosis (around 75% overall survival at five years).11 
ALK-negative sALCL, on the other hand, usually 
occurs in the elderly with a poor overall survival rate 
of less than 25% at five years.11
As demonstrated in this patient, ALCL also 
strongly expresses CD30 antigen, which promotes cell 
proliferation and survival, upregulates the susceptibility 
to apoptosis signalling and downregulates the immune 
response. All of these factors make CD30 antigen an 
attractive target for diagnosis and targeted treatment 
with brentuximab vedotin (the anti-CD30 antibody).12 
Thus, IHC detection of characteristic molecular 
alterations provide unprecedented targets for the 
management of ALCL. 
The session concluded with the student 
acknowledging the unique patient-to-laboratory 
learning journey he had undertaken through this 
patient’s disease complexities; exhorting his peers in 
the audience to replicate such learning opportunities in 
their clinical years and beyond.
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presenter-audience dialogue. It is a golden opportunity 
for the novice medical clerk to embark on a journey 
of exploration, confidence and communication. 
This SCRAPS presentation serves to emphasise the 
significance of the physician-pathologist dialogue 
where balanced use and interpretation of sophisticated 
tests and imaginative educational methods extended 
beyond the curriculum to groom physicians-in- 
the-making.
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Epilogue
The narrative of this patient is evocative of secondary 
cancers (post-BMT lymphoproliferative disorders), 
iatrogenic outcomes (infectious predisposition), the 
challenges of technology (IHC), and cutting-edge 
personalised medicine (molecular targets in oncologic 
practice). All of these provide the learning content that 
the SCRAPS arena aims for. However, in this interactive 
SCRAPS presentation, one of an infinitesimal number 
of strategies medical educators can adopt was used 
to make the clinico-pathological session a simulated 
exercise in reality.2 Integrated curricula in leading 
educational centres have introduced other methods 
like pathology special study modules or pathology-led 
problem-based learning to achieve this synthesis.13 
A recent review from the USA recommended the 
inclusion of the vital competency of ‘diagnostic 
medicine’ overseen by the Liaison Committee on 
Medical Education to fulfil holistic integration of the 
laboratory with clinical practice.14 Curricular time in 
clinical years often precludes allotting additional hours 
to revisit the laboratories. The concept that assessment 
drives learning has prompted UK educators to suggest 
that objective structured clinical examinations in 
clinical assessment should include pathologists in the 
design and evaluation process.15 
A common phenomenon in medical students’ 
learning is emphasis on the concept and neglect of 
procedural knowledge of laboratory inputs, which 
can later lead to poor strategising when requesting 
and interpreting tests.16 This case presentation brings 
this issue to the fore and makes a case for finding 
more opportunities to reinforce laboratory education 
beyond the didactic curricular hours, perhaps in the 
format of interprofessional education.17 Novel medical 
curricula, including the World Federation for Medical 
Education-accredited integrated curriculum offered at 
the COMHS of SQU, abound in innovative strategies 
for improving the teaching skills of students.18–20 The 
SCRAPS forum is one more arena where this can be 
effectively practiced. The art of problem-solving and 
the shaping of professional identity is an integral 
part of development for the budding physician;21 
brain storming and in-depth discussions prior to 
such presentations identify grey areas in learning for 
the learner-presenter, the educator and the target 
audience; the outcome benefits all three.
Grounded in the grim environs of disease and its 
increasing complexities, learning and teaching can 
be made mutual and responsive. It can and should 
achieve a new dimension to the teacher-taught 
relationship; embed student-peer learning; integrate 
clinical, basic and diagnostic specialties; and forge 
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CME Quiz Questions





d. Squamous cell carcinoma






2. A specialised histotechnique commonly used in identifying 





7. Which one of the following groups of chemotherapy is most 











8. A total of 85% of ALCL patients have a translocation, t(2;5) 
leading to NPM-ALK fusion gene, resulting in the translation 
of a 80 kilodalton protein. Which one of the following agents is 











9. Brentuximab vedotin has been approved by the FDA for 





d. Tyrosine kinase inhibitor
5. Which antigen expressed on the ALCL cell also serves as a 





10. t(2;5) is present in 85% of ALCL cases. If present, the 
marker could be used for which of the following purposes? 






ALCL = anaplastic large cell lymphoma; ALK = anaplastic lymphoma kinase; Bcl-2 = Bacillus collagen-like antigen 2; CD = cluster of differentiation; 
NPM = nucleophosmin; FDA = Food and Drug Administration.
